Published: 2022-01-28

Assessment of serum uric acid level among patients with rheumatoid arthritis

Hassan Y. Roble, Rosy Sultana, Mohammad Moniruzzaman, M. Zahid Hassan


Background: Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily effects elderly population and commonly involves pain in the joints (the wrist and hands). Gout is a form of arthritis caused by excess uric acid in the blood stream, which can affect several joints. The co-occurrence of RA and gout in the same patient is rarely reported. The aim of this study was to assess the level of serum uric acid among patients with RA, and to observe any associations of serum uric acid levels with RA.

Methods: In a descriptive cross-sectional study, a total of 70 blood samples were collected from patients. Anti-cyclic citrullinated peptide (anti-CCP) antibodies measured by ELISA method, serum C-reactive protein (CRP), Rheumatoid factor (RF) measured by latex agglutination test and serum uric acid levels measured with semi-autoanalyzer were carried out. Data was analyzed using a statistical package for social science for windows version 15.0. A p<0.05 was taken as level of significance.

Results: Out of a total of 70 subjects, 15 (21.4%) were positive for RF, anti-CCP antibodies positivity was present in 10 (14.3%) of the cases and serum high sensitive CRP was present in 36 (51.43%) of the cases. Of 70 cases. The 50 had hyperuricemia (23 male vs 27 female). Distribution of subjects having a high serum uric acid level on the basis of RF, anti-CCP Ab, and CRP status were statistically different.

Conclusions: The present study summarizes the level of uric acid in patients with RA (either seropositive or seronegative arthritis). The data concluded that serum uric acid did not show association with RA as revealed by the lack of association with specific markers.


Anti-CCP Ab, Gout, RA, Uric acid

Full Text:



Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(6):vi5-9.

Wong SH, Lord JM. Factors underlying chronic inflammation in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 2004;52(6):379-88.

Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005;32(2):348-53.

Mavrogeni S, Dimitroulas T, Bucciarelli-Ducci C, Ardoin S, P Sfikakis P, Kolovou G et al. Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance. Curr Drug Targets-Inflammation Allergy. 2014;13(2):81-93.

Corrao S, Argano C, Calvo L, Pistone G. The challenge of using the rheumatoid arthritis diagnostic criteria in clinical practice. Intern Emerg Med. 2015;10(3):271-5.

Eker YÖ, Pamuk ÖN, Pamuk GE, Dönmez S, Çakır N. The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study. Eur J Rheumatol. 2014;1(2):67.

Braschi E, Shojania K, Allan GM. Anti-CCP: a truly helpful rheumatoid arthritis test? Can Fam Physician. 2016;62(3):234.

Handa R. Approach to seronegative arthritis. Sarcoidosis. 2003;4:3.

Hainer BL, Matheson E, Travis Wilkes R. Diagnosis, treatment, and prevention of gout. Am Fam Physician 2014;90:12.

Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8-14.

Álvarez-Lario B, Macarrón-Vicente J. Uric acid and evolution. Rheumatology. 2010;49(11):2010-5.

Gnjidić Z. Epidemiology and risk factors for gout. Reumatizam. 2012;59(2):82-8.

Merriman T, Dalbeth N, Johnson R. Sugar-sweetened beverages, urate, gout and genetic interaction. Pacific health dialog. 2014;20(1):31-8.

Jebakumar AJ, Udayakumar PD, Crowson CS, Matteson EL. Occurrence of gout in rheumatoid arthritis: it does happen! A population-based study. Int J Clin Rheumatol. 2013;8(4):433.

Bernal JA, Quilis N, Andrés M, Sivera F, Pascual E. Gout: optimizing treatment to achieve a disease cure. Ther Adv Chronic Dis. 2016;7(2):135-44.

Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheumatic Dis. 2010;69(01):70-81.

Towiwat P, Li ZG. The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout. Int J Rheum Dis. 2015;18(5):495-501.

Olaru L, Soong L, Dhillon S, Yacyshyn E. Coexistent rheumatoid arthritis and gout: a case series and review of the literature. J Clin Rheumatol. 2017;36(12):2835-8.

Kozin F, McCarty DJ. Rheumatoid factors in the serum of gouty patients. Arthri Rheumati. 1977;20(8):1559-60.

Roddy E, Doherty M. Gout. Epidemiology of gout. Arthritis Res Therapy. 2010;12(6):223.

Agudelo CA, Turner RA, Panetti M, Pisko E. Does Hyperuricemia Protect from Rheumatoid Inflammation? Arthritis Rheum. 1984;27(4):443-8.

Baker DL, Stroup JS, Gilstrap CA. Tophaceous gout in a patient with rheumatoid arthritis. J Am Osteopath Assoc. 2007;107(12):554-6.